News

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...
Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...
Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
from syringes to insulin pens, to an insulin pump, or even with an inhaler. Maintaining blood glucose levels helps reduce the risk of diabetes complications, such as blindness and the loss of limbs.
are at a higher risk of developing diabetes. This trend directly correlates with an increased demand for insulin delivery devices, particularly pen needles, due to their ease of use and minimized ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...
People may choose to manage their diabetes with insulin injections ... This applies to injecting insulin with a syringe, prefilled insulin pen needle, or if you’re using an insulin pump infusion ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Lilly isn’t the first diabetes specialist to tap into Dexcom ... Roche’s diagnostics division – to develop connected insulin pens. “CGMs provide people with diabetes and their healthcare ...
Victoza, produced by Novo Nordisk, holds FDA approval for regulating blood sugar levels among individuals diagnosed with type ...